📊 Evidence-Based Reference

Introducer Catheter

Interventional Therapeutics

Compare similar devices

Summary: The introducer catheter by Interventional Therapeutics is primarily used for vascular access in procedures such as hemodialysis and cardiac surgery. Key evidence highlights complications like thrombosis and rare fatal events.

FDA Clearance Information

Pathway ? 510(k)
Number ? K915625 ↗
Decision Date ? June 3, 1992
Product Code ? DYB
Device Class ? Class 2
Evidence ? 0 studies

The introducer catheter was cleared by the FDA through the 510(k) pathway on June 3, 1992. It is manufactured by Interventional Therapeutics and classified as a Class 2 device.

What It Is

The introducer catheter is a medical device used to facilitate the insertion of other catheters into the vascular system. It is designed for use in procedures requiring vascular access, such as hemodialysis and cardiac catheterization.

FDA-Cleared Indications

  • Facilitate insertion of other catheters into the vascular system.
  • Provide vascular access for procedures requiring placement of catheters.
  • Use in vascular access situations such as hemodialysis or cardiac catheterization when indicated by the product labeling.

Clinical Applications

  • Vascular access during cardiac catheterization and cardiac surgery.
  • Access for hemodialysis when an arteriovenous shunt is not feasible.
  • Placement of diagnostic or therapeutic catheters through a vascular access route.

Reported off-label uses

  • Access sheath or catheter introduction during interventional radiology embolization procedures.
  • Vascular access during selected endovascular procedures involving arterial or venous catheter placement.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes 15 studies, comprising prospective cohorts and case series, published between 2006 and 2022. These studies explore complications and procedural outcomes associated with the device.

Reported Outcomes

Published studies report that the introducer catheter is effective in providing vascular access for hemodialysis and cardiac procedures. However, complications such as thrombosis and rare fatal events during implantation have been documented.

Safety Profile

Reported complications include early-onset thrombosis of the internal jugular vein and rare fatal or near-fatal events during catheter implantation. These highlight the importance of careful procedural execution.

Evidence Limitations

The evidence is limited by a lack of large-scale randomized controlled trials and a focus on specific complications. Further research is needed to explore long-term outcomes and broader safety profiles.

Practical Considerations

  • The appropriate diameter and length depend on the target vessel, access site, and catheter or device that must pass through the introducer.
  • Use only compatible guidewires, dilators, catheters, and accessories specified in the product instructions for use.
  • Insertion is generally performed using sterile technique and imaging guidance, such as ultrasound and fluoroscopy, depending on the procedure.
  • Potential complications include bleeding, infection, vessel injury, thrombosis, air embolism, and loss of access; serious or fatal events are rare but possible.
  • MRI compatibility cannot be determined from the FDA record alone. Check the exact product labeling before MRI, and remove or manage the device according to its instructions for use.

Procedures that use this device

Frequently Asked Questions

What are the clinical indications for introducer catheter?

The introducer catheter is indicated for use in vascular access procedures, such as hemodialysis and cardiac catheterization.

What outcomes have been reported in clinical studies?

Studies report effective vascular access for procedures, but also note complications such as thrombosis and rare fatal events.

What complications have been reported?

Safety data indicate complications like thrombosis of the internal jugular vein and rare fatal or near-fatal events during implantation.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you